Bpi Communications Inc

Connelly & McLaughlin Woloz is a prominent public relations firm based in New York City, specializing in strategic communication and media relations for a diverse range of clients. With a team of experienced professionals, CMW Strategies LLC offers comprehensive services to effectively navigate the ever-evolving landscape of public relations and deliver impactful results.Generated from the website

Ulysses Management LLC is a diversified investment firm based in New York, NY, with over $1 billion in capital under management. Led by Joshua Nash, the firm follows a variety of investment strategies in pursuit of superior long-term investment results. With a focus on partnership and alignment of interests, Ulysses invests in businesses with proven business models, motivated management teams, and enduring free cash flow. Founded over 20 years ago, Ulysses is the successor firm to Odyssey Partners, LP, and continues the tradition of investment innovation in public, private, and alternative markets. The firm emphasizes long-term investment horizons, operational focus, and value creation through close partnership with exceptional management teams. Ulysses also employs rigorous fundamental analysis and risk control in its investment strategies in public markets and hedge fund managed accounts.Generated from the website

Covance, located in Princeton, NJ, offers trusted scientific laboratory services to navigate the complexities of drug development for biopharma companies. Their solutions inform every phase of development, supporting targeted therapeutic indications and emerging treatment modalities. With expertise in nonclinical development, Covance provides scientific knowledge in toxicology, pharmacology, and metabolism to propel drug development programs forward. They offer risk assessments, regulatory guidance, and program management to advance breakthrough medicines in various therapeutic areas. Covance's central laboratory services generate extensive clinical trial data globally, supporting trials in over 100 countries. They assist in defining clinically relevant indicators through biomarkers, genomics testing, and companion diagnostics, aiding in the discovery, development, and commercialization of next-generation therapeutics. Generated from the website content